Apollo Launches Into Myer With New Skincare Range

Main Category: Dermatology
Article Date: 20 Nov 2007 - 3:00 PDT

email to a friend   printer friendly   opinions  

Apollo Applied Science Pty Ltd, the over-the-counter (OTC) marketing division of biopharmaceutical company Apollo Life Sciences (AOP: ASX), has launched a unique range of advanced skincare products to be sold in Myer stores throughout Australia.

Apollo's Ellipse Skin Science products use the company's patented Intradel™ nano-technology as well as micro-droplet emulsion and oil / water cream emulsion technologies to provide superior skincare protection and rejuvenation. Apollo's Intradel™ technology is used to deliver nano-sized water droplets, which carry ingredients that protect and rejuvenate skin, deep into the skin.

According to Mr Nick Cakovski, General Manager of Apollo's OTC Marketing Division, most skincare creams on the market today are a simple mixture of oil and water that rarely penetrate beyond the surface layers of the skin. "To effectively moisturise the skin and reduce the visible appearance of wrinkles and cellulite, you need to deliver ingredients deep into the skin," said Mr Cakovski.

Apollo's Head of Drug Delivery Dr Michael Luke explained that the company's Intradel™ nano-droplets are up to ten times smaller than oil droplets contained in regular creams and their distinctive composition allows them to squeeze through the skin.

"The components of Intradel™ which force the water into nano-droplets are made of biocompatible and biodegradable ingredients commonly used in foods, and are approved by the US Food and Drug Administration," added Dr Luke. "Apollo is using cutting edge nano-technology to deliver skincare ingredients to the site of action," said Dr Luke.

While the core function of Intradel™ nano-technology is to meet the worldwide demand for needle-free prescription drug delivery systems, the technology's versatility has allowed Apollo to move into skin care products that have a lower barrier to market entry compared to therapeutic drugs.

Apollo CEO John Priest said the adaptability of Intradel™ will allow Apollo to generate cash flow while the company progresses clinical trials of its needle-free therapeutic drugs which are designed to treat diseases such as psoriasis and rheumatoid arthritis.

"Apollo is continually exploring innovative ways to commercialise its unique topical delivery technologies," said Mr Priest. "With distribution in Myer stores, Apollo's Ellipse Skin Science products have the potential to generate a healthy cash flow for the company. We also have plans next year to sell our skincare products into retail stores in the USA - sales brokers and distributors have already been arranged," said Mr Cakovski.

Marketing intelligence firm Packaged Facts estimated US skincare sales for 2006 at US$5.8 billion. In its study, Skincare Products in the US, the company predicted the market will reach US$7.2 billion by 2010, with an annual growth rate of 11.3 per cent driven by expected double-digit growth of anti-aging products, which are likely to become the second largest category behind hand & body lotions1.

"We view the Myer order for Ellipse Skin Science products as a major endorsement of Apollo's Intradel™ technology. To add freshness to the marketplace, department stores are always looking for new cosmetic products that use technologies that are different to old brands - Apollo's range of Ellipse Skin Science products has successfully addressed this need," said Mr Cakovski.

1. International Cosmetic News. 1 February 2007

Myer Announces Exclusive Australian Launch Of Ellipse Skin Science

Nano-technology - the latest buzzword in cosmeceutical skincare is now available in an exciting new scientifically developed, Australian brand. Myer, a proud supporter of Australian brands, is very excited to announce the exclusive distribution for Ellipse Skin Science.

"Myer has always been committed to giving our customers access to the latest in skin care technologies, and in line with this, we are very proud to be launching the revolutionary technology created by Ellipse Skin Science. Their patented "IntradelTM" technology is at the forefront of cutting edge skincare - and will renew and rejuvenate many Australian faces." Greg Royans - Business Manager Cosmetics.

"Particularly refreshing is that this is an Australian brand. Not only is it Australian, but we are bringing our customers a brand which has been designed utilizing the latest advances in scientific research at an affordable price which is accessible to all consumers. "

Ellipse Skin Science is available in Myer nationally, in selected stores, from mid December .

* Ellipse is distributed by Apollo Applied Science Pty Ltd, a wholly owned subsidiary of Apollo Life Sciences, an ASX listed company.

http://www.ellipseskin.com

About Apollo Life Sciences Limited

Apollo Life Sciences (ASX: AOP) is an Australian-based biotechnology company with core expertise in the structure and function of proteins. Apollo's extensive library of over 90 human proteins is a rich source of candidate biopharmaceuticals such as the anti-TNF ALS-00T2 used for psoriasis treatment. Apollo's library of proteins is generating early sales revenues from research and diagnostic testing.

Apollo has leveraged its accumulated knowledge of proteins to improve drug delivery methods of accepted large molecule drugs like insulin that have previously been administered by injection. The Company has developed and patented two major needle-free technologies, the oral Oradel™ platform and the transdermal Intradel™ platform, designed to eliminate patients' discomfort, improve effectiveness and lower the cost of therapeutics in major biopharmaceutical markets. Apollo's lead therapeutic candidates are oral insulin and an oral and topical TNF blocker.

http://www.apollolifesciences.com

• Additional
• References
• Citations